Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Ridiculous discussion!

Why now? Why didn't we go after the BOD when they announced to pay out dividends? That is the biggest mistake they made in my view. Someone on the BOD hired RG which in my view looks like a great move. Someone on the BOD wrote RG's requirements for getting the SP at a $1.00 or above for a minimum of 90 days. Some things the BOD have done right. No question that Swartz played a big role in where we are as did Pohl and other BOD members. Yes most of us would like the old BOD members that remain to step aside for more qualified personel. The direction RG is taking the company so far looks good with the existing BOD.

I have to question if all this really is aimed at driving the share price even lower than where we are by shaking investors confidence in PTSC management past decisions and to discourage new investors from jumping in?

All the best,

Steve



Share
New Message
Please login to post a reply